No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
NVCR250117C43000
- 0.00
- 0.000.00%
15min DelayClose Jan 22 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest43.00Strike Price0.00Turnover0.00%IV60.30%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
NovoCure Opens New Global Headquarters in Switzerland
Investing in NovoCure (NASDAQ:NVCR) a Year Ago Would Have Delivered You a 85% Gain
Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $42
NovoCure (NVCR) Gets a Buy From Piper Sandler
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $38
Wells Fargo Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $40